NutraLife BioSciences, Inc. (NLBS)

NutraLife BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	0	0	0.63	1.26	2.13	3.71
Revenue Growth (YoY)	-	-	-50.10%	-41.14%	-42.51%	107.32%
Cost of Revenue	0	0	0.54	0.75	1.54	2.21
Gross Profit	0	0	0.08	0.51	0.6	1.5
Selling, General & Admin	0	0	4.44	2.48	3.99	3.41
Other Operating Expenses	0	0	0.11	-0	0.06	-0.03
Operating Expenses	0	0	4.56	2.48	3.99	3.41
Operating Income	0	0	-4.47	-1.97	-3.4	-1.91
Interest Income	0	0	1.85	0.92	0.01	0
Interest Expense	0	0	1.85	0.01	0.01	0.13
Other Expense / Income	-	-	1.35	1.82	0.61	-0.13
Pretax Income	0	0	-5.83	-2.89	-4.01	-2.07
Income Tax	0	0	1.86	0.01	0.07	0.17
Net Income	0	0	-7.68	-2.9	-4.07	-2.07
Shares Outstanding (Basic)	-	-	165	146	113	87
Shares Outstanding (Diluted)	-	-	165	146	113	87
Shares Change	-	-	12.43%	29.18%	29.72%	21.59%
EPS (Basic)	-	-	-0.05	-0.02	-0.04	-0.02
EPS (Diluted)	-	-	-0.05	-0.02	-0.04	-0.02
Free Cash Flow	0	0	-0.49	-1.28	-4.53	-0.82
Free Cash Flow Per Share	-	-	-0.00	-0.01	-0.04	-0.01
Gross Margin	-	-	13.34%	40.60%	28.03%	40.42%
Operating Margin	-	-	-713.77%	-157.12%	-159.14%	-51.36%
Profit Margin	-	-	-1226.14%	-231.15%	-190.91%	-55.90%
Free Cash Flow Margin	-	-	-77.78%	-102.27%	-212.26%	-21.99%
EBITDA	0	0	-4.14	-2.48	-3.77	-1.87
EBITDA Margin	-	-	-660.65%	-197.68%	-176.65%	-50.51%
Depreciation & Amortization	0	0	0.33	0.39	0.23	0.07
EBIT	-	-	-4.47	-2.88	-4	-1.94
EBIT Margin	-	-	-712.75%	-229.11%	-187.45%	-52.29%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.